Acrisure is a private company with a high percentage of employee ownership. Its future ambitions are unclear, but it’s positioning itself as a fintech with the potential to be a SaaS, which could attract Wall Street interest.
Explore how to invest in Vanta before its IPO. Learn about the company’s valuation, key milestones, and how retail investors can gain early access to this rising SaaS compliance leader.
Craig breaks down the newly released 2025 CNBC Disruptor 50 List and highlights trends, omissions, and surprises. He picks his 6 favorite new-to-him startups, and showcases an opportunity for U.S.-based…
Miso Robotics is one a mission to reduce unwanted jobs, improve efficiency and safety, and reduce costs for the 300,000 quick-service restaurants in the U.S. That’s before international expansion.
Explore opportunities to invest before the Replit IPO date. Monitor the latest share availability on the Hiive secondary marketplace to buy or sell Replit stock pre-IPO. Notable Replit News 04/02/2025:…
Fintech IPOs are back after a few years of very little activity. The Circle IPO explosion will encourage the next round of IPOs from companies like Klarna, Chime, Gemini IPO,…
Liquid Death is a sparkling water brand that uses humor and viral social media videos to drive consumer demand. The company is raising private equity capital and may be headed for an IPO. Can ordinary investors buy shares yet?
Not all IPOs are the same. Depending on the number of shares, the amount raised, and, most importantly, investor demand, IPOs start trading at different times. The highest-profile IPOs may surprise you when they typically start trading.
Genesys may be heading for an IPO debut in 2025. Learn about its valuation, private equity backing, and how investors can gain exposure before and after this potential cloud software giant goes public.
The IPO window is open, and it’s time for private companies to move forward with filings so they don’t miss it. Craig examines recent IPO data that suggests the IPO…
Anthropic’s Claude is chasing ChatGPT to become a leading A.I. LLM for text generation. While the company maintains a strong commitment to A.I. safety and research, its goal is to be a leading for-profit player in the A.I. domain over the next decade.
Medline’s IPO is in motion, with private equity firms aiming for a $50B valuation. Strong fundamentals and a massive potential exit make this one of the most anticipated healthcare offerings this year.